Published on : Feb 12, 2016
Presently, the modernization of healthcare is on the developmental agenda of most countries. This includes end-to-end development right from infrastructural development to enhancing technological capabilities to hiring experts that are trained for modern medical practices. With the increasing incidence of diseases related with several causes, proper record keeping for investigating the causes is vitally important. Adequate clinical research for understanding causes of these diseases and the symptoms that are exhibited at the time of breakout are important to be understood as well. This requires software systems for recording and interpreting data.
The deployment of clinical trial management system (CTMS) have proven to be worthwhile for several reasons. Rising R&D investments for pharmaceutical and life sciences research has empowered research institutions to carry out clinical trials effectively and efficiently, which require advanced systems for record keeping of clinical trial results. Furthermore, hospital information system (HIS) if integrated with CTMS enables esay access to clinical trial results for therapeutics. Thus, considerable time is saved for patients of critical care.
On a geographical outlook, North America is a hotspot for clinical research. Some of the reasons for this are presence of modern infrastructure, presence of experts, and availability of funds for the purpose. In the U.S., clinical trial pursuits receive support from highly acclaimed institutions such as the National Institute of Health for well-founded research. Nevertheless, over the past few years, clinical development is increasingly outsourced to countries such as China and India for high-quality work at competitive costs. Legal and regulatory considerations in developed countries such as the U.S., the U.K. have been reasons for outsource of clinical research to developing countries.
In Europe, Eastern and Central European countries receive ample support for clinical development to provide evidence-based patient care. In particular, Germany is a preferred location for these pursuits, substantial government support that provides knowledge workers and finds for biomedical sciences are reasons for this. This leads to the deployment of clinical trial management system for proper record keeping of results and conclusions of clinical trials for patient care. However, in many countries, clinical trials are forbidden for cultural sentiments and ethical beliefs of the population that are detrimental for modernization of healthcare in these regions.